Emory, Children’s Healthcare of Atlanta launch COVID-19 Vaccine Trial for Young Children

Physicians from Emory and Children’s Healthcare of Atlanta are participating in a clinical trial testing the Moderna COVID-19 vaccine in children ages six months to less than 12 years.

stock image of a boy in a mask giving the thumbs up sign
This is the same Moderna mRNA-1273 vaccine that is being distributed nationwide for adults ages 18 and older following an emergency use authorization from the US Food and Drug Administration in December for that age group. 

The initial phase of the KidCOVE study will test different doses of the vaccine to evaluate safety in a younger population. Children enrolled in the trial at the Emory Children’s Center beginning in May. The study is being conducted by the Infectious Diseases Clinical Research Consortium in collaboration with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and the Biomedical Advanced Research and Development Authority.

“This is a critical step for children that could make it possible for them to receive the same type of immune protection now provided to adults,” says Evan Anderson, associate professor of medicine and pediatrics at Emory, attending physician at Children’s, and the study site principal investigator for the trial. 

Anderson, who has advocated for COVID vaccine clinical trials to begin in children, was site principal investigator for the phase 1 study of mRNA-1273 last year, which showed that the vaccine was safe and generated an immune response in adults. He also was a site principal investigator for the phase 3 study in adults. 

Share This Story